To determine whether adding blood to a cardioplegic solution affects myocardial preservation, a randomized prospective study was carried out in 60 patients undergoing coronary revascularization to compare the effects of crystalloid potassium cardioplegics (group C) and potassium cardioplegic solutions to which blood has been added (group B) on markers of myocardial metabolism (lactate, inorganic phosphate, base deficit release, glucose and lactate uptake, oxygen extraction), myocardial damage (creatine kinase [CK]-MB levels), and cardiac performance (cardiac index and left atrial pressure). The solution with added blood had a significantly (p < .05) greater oxygen content, a lower pH, and higher concentrations of potassium, calcium, sodium, and glucose. In group B patients there was a suggestion (p < .06) of greater uptake of oxygen during the beginning of the initial cardioplegic infusion. During reperfusion there was no evidence of differential release of the metabolites of anaerobiosis and myocardial oxygen extraction and glucose and lactate uptake were similarly depressed in both groups. Likewise, CK-MB release after bypass was the same in both groups. Prompt, adequate functional recovery of cardiac index and left atrial pressure was observed in-both groups. It was concluded that although there may be more oxygen available from the blood-containing solution during early infusion, there is no evidence that under the conditions of this investigation adding blood to cardioplegic solution improves myocardial preservation. Circulation 69, No. 5, 973-982, 1984. From the
ALTHOUGH blood-containing cardioplegic solutions have been shown to provide adequate myocardial protection during periods of aortic occlusion,'-' their use in preference to blood-free crystalloid solutions is still controversial. The inclusion of blood in cardioplegic solutions was devised as a means to enhance their myocardial protective characteristics, mainly through increased oxygen-carrying capacity. However, the value of blood as a means of delivery of oxygen to the myocardium has been questioned.9-'' The benefit of blood as a constituent of the cardioplegic solution may vary depending on the temperature and method of administration.3' 10 To explore whether addition of blood to a cardioplegic solution could affect myocardial preservation, a randomized prospective study was conducted to compare the effects of blood-free crystalloid and blood-containing cardioplegic solutions on markers of myocardial metabolism, myocardial damage, and cardiac performance in 60 patients undergoing coronary artery bypass surgery.
Methods
Sixty patients scheduled for elective coronary artery revascularization were studied in a protocol approved by the institutional review board of the University of Alabama in Birmingham.
They were assigned to receive either a blood-containing (group B, n = 31) or a clear crystalloid (group C, n = 29) potassium cardioplegic solution by the use of a table of random numbers. Demographic data describing the patient population are listed in table 1. When the left ventriculogram showed significant areas of hypokinesis, akinesis, or dyskinesis, ventricular function was considered abnormal.
Surgical management and anesthesia. To ensure consistency in the surgical technique and management, all surgery was performed by the same surgeon and all patients received the same anesthesia. Venous cannulation was accomplished with a two-stage single venous cannula (William Harvey, Bard, type 1969) . All patients had proximal anastomoses performed while on bypass before aortic cross-clamping. The distal anastomoses were completed during one period of continuous aortic occlusion. Complete revascularization was attempted in all patients.
The perfusate consisted of Normosol-R (1000 ml) and n solution (1000 ml) of 5% dextrose in 0.45% sodium chloride. Cardiopulmonary bypass was established at a flow rate of 1.6 to When higher pressures persisted at a flow of 1.3 liter/min/m2, droperidol or nitroprusside was administered. Low perfusion pressures were not treated. The perfusate temperature was maintained at 300 C while the proximal anastomoses were completed and it was lowered to 120 C for myocardial precooling before aortic occlusion. The perfusate temperature was then maintained at 26°C until rewarming during completion of the two last anastomoses.
Anesthesia was induced with diazepam and maintained with fentanyl, nitrous oxide, halothane, and pancuronium. Additional doses of diazepam and pancuronium were administered at the onset of cardiopulmonary bypass.
Monitoring. A No. 18 radial artery catheter for continuous monitoring of systemic arterial pressure and for sampling of blood was placed during induction of anesthesia. Left and right atrial pressures were monitored continuously. Before bypass, a pulmonary artery thermistor (No. 2F, Wilton Webster Laboratories) was inserted for determination of cardiac output and a catheter was introduced through the right atrium into the coronary sinus. Cardiac output was measured in duplicate before bypass and 5 and 30 min after discontinuation of bypass. Septal myocardial temperature was continuously monitored during aortic occlusion and in the reperfusion period.
Cardioplegic solutions and their administration. The crystalloid potassium cardioplegic solution was formulated to contain, per liter: 30 meq potassium, l meq calcium, 113 meq sodium, 113 meq chloride, 27 meq bicarbonate, 10 g mannitol, and 5 g dextrose. The cardioplegic solution to which blood was added was prepared after cardiopulmonary bypass was established by the addition of 400 ml of perfusate blood obtained from the cardiopulmonary bypass pump reservoir to 1 liter of the crystalloid cardioplegic solution. To compensate for the dilution of potassium resulting from the addition of blood, 10 meq of potassium was also added to the mixture. Measured contents of each solution are listed in table 2.
Both solutions were administered into the aortic root at a temperature of 40 C by a roller pump through a separate heat exchanger and a bubble trap at a flow of 150 ml/min2. The solution was kept cold between administrations by recirculation through the heat exchanger. The initial cardioplegic infusion was begun immediately after aortic cross-clamping and lasted for 3 min. Cardioplegia was repeated for 2 min every 30 to 40 min, when myocardial temperature exceeded 180 to 20°C. or upon evidence of returning myocardial activity. To aid rapid myocardial cooling and maintenance of low myocardial temperatures, the pericardial cavity was intermittently flooded with iced saline solution.
Reperfusion. Myocardial reperfusion was accomplished after construction of all vein grafts by release of the aortic crossclamp at a pump flow of 1.6 liter/min/m2 and at a perfusate temperature of 300 C for 2 min followed by a flow of 2.2 liter! min/m2 and rewarming. The patients were weaned from bypass after the 9 min reprefusion samples were obtained when the nasopharyngeal temperature had reached at least 36.5°C and a sinus rhythm had been established or atrial pacing was possible.
Measurements. Blood samples from the coronary sinus were taken just before going on bypass, during the first minute of reperfusion after the release of the aortic cross-clamp, at 3, 5. 7, and 9 min of reperfusion, 5 min after discontinuation of bypass, and 30 min after bypass. Each sample was assayed for lactate, blood sugar, inorganic phosphate, creatine kin-ase (CK)-MB. and electrolyte (potassium, sodium, calcium) levels, and blood gases (pH, Paco2, Po2). Arterial blood CK-MB levels were measured in all patients 10 hr after bypass. In the last 33 patients, arterial blood was sampled simultaneously with coronary sinus blood at the time points specified above and analyzed as previously described. In the last 18 patients, coronary sinus oxygen content and norepinephrine and epinephrine concentrations were determined during infusions of cardioplegic solution. Coronary sinus samples were drawn at 90 to 120 sec and 150 to 180 sec of the initial cardioplegic infusion. Each solution was analyzed for hematocrit, potassium, calcium, and sodium after completion of the last infusion. Left atrial pressures and cardiac output measurements were obtained before and 5 and 30 min after bypass and the cardiac index and peripheral vascular resistance were calculated. Cardiac output was measured with a Gould Statham cardiac output computer SP 1424. Lactate and serum blood sugar concentrations were determined enzymatically with lactic dehydrogenase in a Beckman spectrophotometer at 340 nm, and glucose oxidase in a Yellow Springs YSI Model 23A analyzer. 12. 1 ' Inorganic phosphate was measured colorimetrically according to the method of Fiske and Subbarow. '4 CK-MB was assayed by the Rosalski method after separation by column chromatography.'
Norepinephrine and epinephrine levels were determined by high-performance liquid chromatography with electrochemical detection by a modification of the nmethod of Keller et al. '6 Potassium and sodium were measured by flame photometry with an Instrumentation Laboratory analyzer. Determination of ionized calcium was made with a Nova Biomedical-Nova 2 instrument with an ion-specific electrode. The pH, Po2, and Paco2 were analyzed with ion-specific measurement methods with the use of an Instrumentation Laboratory pH and blood gas analyzer (813) with cooximeter (282). Blood and fluid oxygen contents (°2) were calculated with Severinghaus' line charts for computation of oxyhemoglobin dissociation correction for pH and temperature'7 and by published solubility coefficient tables for gases.8
Myocardial oxygen extraction (percent) was calculated as follows:
Cardioplegia (0°) -Coronary sinus (07) x 1()0 Cardioplegia (0) Statistical analysis. Comparisons over time for the total population were done with analysis of variance techniques, adjusting for each patient as his own control. Analysis between groups over time was done with a repeated measures in time analysis, adjusting for each patient as his own control. Overall differences were tested if there was no group-time interaction effect noted. If a group-time interaction effect was present. group differences were tested at each individual time point.
Results
Except for the presence of left main coronary artery disease and antihypertensive therapy, patient characteristics were similar in the two study groups (table 1) . Aortic occlusion time, volume of cardioplegic solution infused, amount of potassium given with the cardioplegic solution, septal myocardial temperature, and number of coronary bypass grafts were not significantly different between the groups. Furthermore, the times from initiation of cardioplegia to myocardial quiescence and from aortic unclamping to resumption of myocardial electrical activity and to discontinuation of bypass were not significantly different. The heart was considered quiescent when all evidence of electrocardiographic activity ceased and quiescence was confirmed by a visual check of the heart. The time of resumption of myocardial activity was defined as the time at which the first activity was noted on the electro-Vol. 69, No. 5. May 1984 cardiogram. For this purpose limb lead II of the electrocardiogram was watched on the oscilloscope and a continuous record at a paper speed of 5 mm/sec was obtained during these periods. Contractile myocardial activity resumed during reperfusion in 22 of the 31 patients in group B and 17 of the 29 patients in group C. In the other patients, myocardial activity resumed with ventricular fibrillation or there was an episode of ventricular fibrillation during reperfusion requiring at least one electrical defibrillation (table 3) .
There was no perioperative mortality or hospital deaths in the patients studied. The hemodynamic values (cardiac index, left atrial pressure) were similar ini both groups before bypass and 5 and 30 min after bypass (table 4) . None of the patients in group B required inotropic drug support at any time during the course of surgery, but two patients in group C required catecholamine infusion to generate an adequate cardiac output after discontinuation of cardiopulmonary bypass. One of these had increasing inotropic support requirements and had an episode of ventricular fibrillation in the immediate postoperative period. Both of these patients had enzymatic and electrocardiographic evidence of myocardial damage. Their further postoperative clinical course was uncomplicated and they were discharged in satisfactory condition on the eighth and ninth postoperative days. Two patients, one in each group, were kept in the hospital beyond the tenth postoperative day because of ventricular arrhythmias. One of these patients had a hospital course further complicated by a leg wound infection, which delayed discharge until the thirty-fourth postoperative day. The other patient was discharged on the fourteenth day. Another patient had a wound infection requiring sternal debridement 8 days after his original surgery and was discharged on the twenty-eighth postoperative day. All other patients had a satisfactory postoperative course and were discharged between the seventh and tenth postoperative days. Cardioplegic solution. The mean ( SD) hematocrit level in the blood-containing solution was 6.3 + 2.5. The temperature-corrected oxygen tensions of both solutions were similar, but oxygen content of the two solutions differed significantly. The solution with added blood contained measurable amounts of norepinephrine and epinephrine ( marginally (p -.06) greater with blood-containing than with clear solution. When sampled at end-infusion (150 to 180 sec), the slight difference between groups in arteriocoronary sinus oxygen content disappeared ( figure 1 ). Oxygen extraction from the clear solution was significantly (p = .002) greater at both 90 to 120 and 150 to 180 sec of infusion (figure 1). Norepinephrine and epinephrine were released from the heart during cardioplegic infusion in both groups. The norepinephrine concentration in the coronary sinus was highest toward the end of cardioplegic infusion, suggesting progressive release from the heart in the course of the infusion. In contrast, coronary sinus epinephrine concentrations remained stable throughout the infusion period. There were no significant dif-ferences in catecholamine levels in the coronary sinus between the groups (figure 2).
Reperfusion. There were no differences between groups in myocardial elaboration of products of anaerobic metabolism. Lactate was released from the heart during reperfusion after release of the aortic crossclamp and taken up at 30 min after bypass in both groups ( figure 3 ). Washout of inorganic phosphate occurred during early reperfusion in both groups (figure 4) . A short-lived release of acid metabolites from the heart was demonstrated by a more negative base excess (greater base deficit) in the coronary sinus blood relative to arterial blood during initial reperfusion ( figure 5 ). The course of release was almost identical in the two groups. Coronary sinus Po0 after re- lease of the aortic cross-clamp was significantly greater than that observed before bypass and it decreased rapidly toward prebypass values as reperfusion progressed ( figure 6 ). Aortocoronary sinus differences in oxygen content were decreased during the initial reperfusion period, and increased with progression of reperfusion. There were no significant differences between the groups ( figure 7) . Oxygen extraction by the heart was severely depressed after aortic unclamping. Extraction increased rapidly within the first 5 min coincidental with rapid rewarming and return of myocardial activity, but remained significantly depressed dur- ing the entire 9 min of reperfusion. At 5 min after bypass it was still minimally depressed. Thirty minutes after bypass oxygen extraction approached prebypass levels. There were no significant differences in the percent of extraction between the groups (figure 8 ). CK-MB isoenzyme levels in the coronary sinus blood increased minimally over prebypass levels during reperfusion. There were further small increases at 5 min, 30 min, and 10 hr after bypass. No significant differences between'the groups with regard to these determinations were found ( figure 9 ). Arteriocoronary sinus differences in glucose showed a depression of myocardial glucose uptake in the reperfusion period. Glucose uptake recurred in late reperfusion and uptake increased toward prebypass levels at 30 min after bypass. This finding was also similar in both groups ( figure 10 ). integrity during ischemia. 1 3^' In contrast, several arguments have been put forth that call into question the beneficial effects of cardioplegic solutions containing cold blood; the augmented oxygen-carrying capacity of cardioplegic solutions with added blood may not be of practical benefit because the efficiency of oxygen delivery to myocardial tissue is markedly reduced under the conditions of administration of the solutions.9' 1 21 Low temperature, high pH, and low Pco2 increase the oxygen affinity of hemoglobin and decrease oxygen release at the tissue level. Also, the addition of blood to the solution increases its viscosity and creates the potential for sludging of cells and platelet aggregation in the microcirculation. '1' 20 Uptake of potassium by the red cell could potentially reduce the extracellular potassium below cardioplegic levels and 
Discussion
The purpose of this study was to determine whether addition of blood to a cardioplegic solution improves myocardial protection during aortic occlusion. There are several theoretical arguments that support the notion that blood-containing cardioplegic solutions offer superior myocardial preservation; inclusion of blood has been proposed as a means of increasing the oxygen-carrying capacity of the solution" ''9 and supplying oxygen to the heart with cardioplegic infusion should ensure aerobic metabolism during induction of cardioplegia. This may preserve cellular energy stores and make maximal energy reserves available for the ensuing ischemic period. 19, 20 Availability of oxygen during cardioplegic reinfusion might replenish at least some of the energy stores lost during ischemia.' 7 Blood-containing solutions have further been recommended for their buffering capacity, their colloid osmotic pressure, and their content of metabolic substrate, which may support metabolism and cellular cause premature return of electromechanical activity.3 Endogenously released catecholamines present in the solution may increase basal myocardial metabolism and promote calcium entry into the cell, diminishing the beneficial effects of cardioplegia.22 23 The blood-containing solution (mean hematocrit 6.3%) contained significantly more oxygen than the clear crystalloid solution (3.35 vs 0.51 vol%, p = .001). If better myocardial protection were achieved by the blood-containing solution because of its greater oxygen content, then more oxygen should be available to the heart, taken up by the heart, and utilized by the myocardium. There was a marginally greater (p = .06) arteriocoronary sinus effluent difference in oxygen content at midinfusion (90 to 120 sec) with the blood-containing solution, suggesting greater oxygen availability and uptake with its use. Toward the end of the infusion (150 to 180 sec) the arteriocoronary sinus difference in oxygen content was reduced, indicating and warm heart diffuses into the solution. The higher temperature and concomitant decrease in pH favor release of oxygen from hemoglobin, making it more available to the heart. As contractile activity ceases and myocardial temperature drops, the affinity of oxygen for hemoglobin becomes greater, causing the arteriocoronary sinus oxygen content difference to decrease. A decline in arteriocoronary sinus difference in oxygen content was also noted in patients in whom clear cardioplegia was used. All oxygen contained in the clear solution is unbound and is available for diffusion into the tissue. A decrease in cardioplegic solu-tion-coronary sinus oxygen content difference during infusion with the clear solution suggests that myocardial oxygen demand or oxygen uptake may be reduced below the supply when cooling and cardioplegia become established. This would tend to diminish the importance of including an oxygen carrier in the cold cardioplegic solution. Alternately, changes in flow rather than oxygen utilization could account for the changes in the cardioplegia-coronary sinus effluent differences observed. Flow was not measured and therefore the possibility that changes in flow influenced the results could not be ruled out. However, the rate of cardioplegic infusion was not changed during administration of the solution so that important fluctuations in flow were unlikely. Measurable concentrations of catecholamines were present in the bloodcontaining solution, but this did not result in significant differences between groups in catecholamine concentrations in coronary sinus effluent during initial infusion. Toward the end of the infusion, the coronary sinus concentrations of norepinephrine increased in both groups, suggesting that the release of endogenous norepinephrine was augmented in both, and this was perhaps related to hypoxia and hypothermia. 24 25 Accumulation of products of anaerobic metabolism during ischemia and their subsequent washout during reperfusion are related to the magnitude of the oxygen deficit and to the intensity of anaerobic metabolic activity during the ischemic period. Blood from the coronary sinus obtained at reperfusion was analyzed for lactate, inorganic phosphate, and negative base excess (base deficit) as indicators of anaerobic metabolism. Analysis of the magnitude of the arteriocoronary sinus lactate differences during early reperfusion provides information about anaerobic glucose metabolism. Lactate did accumulate during ischemia and was released by the heart during reperfusion, but there were no differences between groups with respect to lactate release. Utilization of adenosine triphosphate continues during cardioplegia, although in greatly decreased amounts. Regeneration of adenosine triphosphate under anaerobic conditions can proceed by transfer of a high-energy phosphate from creatine phosphate to adenosine diphosphate or through the energy gained from conversiosn of glucose to lactate. Since phosphocreatine availability and glycolysis are limited during ischemia, more phosphate bonds are cleaved than generated, causing inorganic phosphate to accumulate. There was evidence of inorganic phosphate washout during reperfusion in the patients in this study, but no differences in washout between groups was detected. Base excess reflects the nonrespiratory acid-base balance in the blood. Acid metabolites as end products of anaerobic metabolism accumulate during ischemia and are released into the circulation during reperfusion. Reperfusion release of base deficit therefore reflects the state of anaerobiosis during aortic occlusion. The results of this study indicate a very short-lived release of acid that is similar in patients receiving clear and those receiving blood-containing cardioplegic solutions.
Alterations in myocardial metabolism occur after cardioplegic arrest and ischemia.4 This investigation looked at the time required for normalization of myocardial oxygen extraction and recurrence of lactate and glucose reuptake during reperfusion. Postischemic increases in coronary sinus Po2 and defects in oxygen extraction, possibly caused by mitochondrial dysfunction, have been well documented.4 2S28 Such defects were observed in both groups. Both lactate and glucose are normally taken up and metabolized by the heart, depression and subsequent recovery of uptake reflect metabolic derangements and their recovery. Uptake of these two substrates was depressed equally in both groups. The delay in recovery of normal metabolic activity until after discontinuation of bypass suggests that metabolic recovery is delayed beyond functional recovery, as has been previously reported. 4 Release of CK-MB was measured as an index of myocardial cellular damage. Only small elevations in concentrations of this enzyme in coronary sinus blood were found during reperfusion. At 10 hr after bypass, when peak levels are expected to be reached, arterial CK-MB levels had risen only minimally. There was no significant difference between groups. These data suggest that myocardial damage sustained during the surgical procedure was minimal in both groups.
The blood-containing solution used in this investigation differs from those used in previously published studies because it has a lower blood content.' 24. 8 Moreover, it was infused at a lower temperature and less frequently than other authors have recommended.3 6. 7 10. 20 As a result, the solution had a lower oxygen content, and less of the oxygen contained in the solution was available to the heart. The longer periods between cardioplegic reinfusion allowed for less frequent replenishment of energy stores and greater accumulation of metabolites during aortic occlusion. This may have decreased the effectiveness of blood cardioplegia and influenced the outcome of the study. On the other hand, lower viscosity and a lower temperature of the solution could potentially affect a more homogeneous and faster cooling and reduce energy requirements more rapidly. This would enhance the protective effect of the solution. This study demonstrated a marginally greater oxygen availability from the solution to which blood was added, at least during the second minute of cardioplegic infusion, yet failed to detect differences in any of the parameters studied.
The absence of mortality and the minimal morbidity in these 60 patients reflect the expectations for the present era of coronary surgery. Excellent functional recovery occurred promptly in both groups, as measured by left atrial pressure and cardiac index determinations. Furthermore, there was no biochemical evidence of superior myocardial preservation in either group, although there appeared to be greater initial Vol. 69, No. 5, May 1984 981 oxygen uptake from the cardioplegic solution with added blood. During reperfusion there was no difference between groups with respect to washout of products of anaerobic metabolism, to time course of recovery to metabolic activity, nor to the postischemic elaboration of CK-MB. It is concluded that bloodcontaining cardioplegic solution, as used in this study, is no more beneficial to the patient than clear cardioplegic solution.
